Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Breast Cancer Diagnostics Market Between 2025 And 2029?
The overall scale of the market concerned with diagnosing breast cancer has seen robust expansion lately, projected to increase from its 2024 valuation of $4.68 billion to $5 billion in 2025, reflecting a consistent annual growth trajectory of 7.0 percent, a rise fueled during the past period by factors such as heightened public consciousness and associated screening initiatives, widespread use of mammography for early detection, continuous progress in diagnostic technologies, the increasing relevance of genetic testing, and the adoption of comprehensive, team-based treatment strategies.
Projections indicate the breast cancer diagnostics sector will experience robust expansion moving forward, anticipated to achieve a market valuation of $6.81 billion by the year 2029, driven by a compound annual growth rate (CAGR) approximating eight percent. This upward trajectory throughout the coming forecast window is fundamentally linked to the increasing implementation of personalized medical approaches, the rising utilization of liquid biopsies, the progression of 3D mammography alternatives such as tomosynthesis, the integration of artificial intelligence and machine learning capabilities, as well as greater reliance on telemedicine platforms for remote patient consultations.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp
Which Drivers Are Supporting Growth Of The Breast Cancer Diagnostics Market?
The rising prevalence of breast cancer necessitates an expanded set of diagnostic tools, consequently fueling greater demand within the breast cancer diagnostics market. Being the most frequently occurring cancer, breast cancer impacts 2.1 million females annually and is responsible for the highest cancer mortality rate among women. The central aim of detecting this disease early is to elevate the proportion of cancers caught in their nascent stages, thereby enabling more efficacious treatment modalities and mitigating the likelihood of mortality stemming from the illness. For illustration, projections released in January 2022 by the American Cancer Society, a US-based entity dedicated to eradicating cancer, estimated that roughly 287,850 new cases of invasive breast cancer alongside 51,400 instances of DCIS would be identified in US women during 2022, with an expected 43,250 deaths linked to breast cancer. Consequently, this escalating rate of breast cancer occurrences is anticipated to be a major impetus for the expansion of the breast cancer diagnostics market.
What Are The Different Segment Classifications Within The Breast Cancer Diagnostics Market?
The breast cancer diagnosticsmarket covered in this report is segmented –
1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers
Subsegments:
1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis
2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy
3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing
4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests
5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing
What Trends Are Expected To Drive The Breast Cancer Diagnostics Market?
Progress in technology serves as a paramount influence shaping the breast cancer diagnostics sector, evidenced by the emergence of multiple novel methodologies applicable for both identifying and managing the disease. Specifically, the imaging procedure termed 3D mammography, or breast tomosynthesis, functions by capturing a series of images around the breast from diverse viewpoints, subsequently compiling these into a three-dimensional representation; furthermore, a notable development occurred in September 2022 when the Indian Health-Tech enterprise Niramai introduced Thermalytix, an advanced screening and diagnostic instrument integrating artificial intelligence with thermal imaging capabilities.
Which Key Market Players Are Investing In Expansion And Innovation Of Breast Cancer Diagnostics Market?
Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report
Which Geographies Are Emerging As Strong Markets For The Breast Cancer Diagnostics Industry?
North America was the largest region in the breast cancer diagnostics market in 2024. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Breast Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp
Browse Through More Reports Similar to the Global Breast Cancer Diagnostics Market 2025, By The Business Research Company
Cancer Biologics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Antibody Drug Conjugates Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model